AbbVie runs ‘Migraine Relief Tok’ calming shorts, but there’s no letup for migraine marketers
AbbVie runs ‘Migraine Relief Tok’ calming shorts, but there’s no [...]
Biogen hits the gas pedal on Aduhelm confirmatory trial, hoping to deliver results in 2026
Biogen hits the gas pedal on Aduhelm confirmatory trial, hoping [...]
In its old age, Bristol Myers’ Orencia becomes first drug approved for preventing graft-versus-host disease
In its old age, Bristol Myers’ Orencia becomes first drug [...]
Eli Lilly trots out rosy 2022 projections, sees recent launches driving two-thirds of its business
Eli Lilly trots out rosy 2022 projections, sees recent launches [...]
Aerami Therapeutics, eager to breeze into smart inhaler market, unveils $250M SPAC deal
Aerami Therapeutics, eager to breeze into smart inhaler market, unveils [...]
CanSino taps Aerogen for development, commercial supply of inhaled COVID-19 vaccine hopeful
CanSino taps Aerogen for development, commercial supply of inhaled COVID-19 [...]
Lawmakers blast pharma for ‘outrageous’ prices and ‘anticompetitive conduct’ in culmination of 3-year probe
Lawmakers blast pharma for ‘outrageous’ prices and ‘anticompetitive conduct’ in [...]
ASH: Sanofi, Johnson & Johnson on collision course with Sarclisa, Darzalex 4-drug regimens in myeloma
ASH: Sanofi, Johnson & Johnson on collision course with Sarclisa, [...]
GlaxoSmithKline vet departs for Vifor, the rumored target of a $7.1B CSL buyout
GlaxoSmithKline vet departs for Vifor, the rumored target of a [...]
Novartis CEO Narashimhan confirms interest in purchase of generics unit Sandoz: report
Novartis CEO Narashimhan confirms interest in purchase of generics unit [...]